Slide 1: Transformational Acquisition of MPC Kinetic (MPK) and Capital Raising
For personal use only TRANSFORMATIONAL ACQUISITION OF MPC KINETIC (MPK) AND CAPITAL RAISING 20 May 2026 Not for release to US wire services or distribution in the United States
Slide 2: Important Notice and Disclaimer
Important Notice and Disclaimer Important Information and Disclaimer The following notice and disclaimer applies to this investor presentation (Presentation) and you are therefore advised to read this carefully before reading or making any other use of this Presentation or any information contained
Slide 3: Important Notice and Disclaimer (con't)
Important Notice and Disclaimer (con’t) Not for release or distribution in the United States This Presentation has been prepared for publication in Australia and may not be released to US wire services or distributed in the United States. This announcement does not constitute an offer to sell, or a
Slide 4: Important Notice and Disclaimer (con't)
Important Notice and Disclaimer (con’t) Financial data (con’t) The Proforma Financial Information incorporates information regarding (i) Genus’ forecast EBIT(A) and EBITDA for FY26; and (ii) MPK’s forecast revenue, EBIT and EBITDA for FY26 (Forecast Financial Information). The Forecast Financial Inf
Slide 5: Contents
CONTENTS ACQUISITION OF MPK AND CAPITAL RAISING 1 Transaction Overview 06 For personal use only 2 Capital Raising Overview 16 3 Appendix 20 4 Key Risks and Offer Jurisdictions 23 5
Slide 6: Transaction Overview
For personal use only SECTION 1 TRANSACTION OVERVIEW
Slide 7: Transaction Highlights
TRANSACTION HIGHLIGHTS Transformational and highly EPS accretive1 acquisition of MPC Kinetic expected to provide strategic diversification into gas and water sector, significant scale, and highly complementary skillsets Genus has agreed to acquire 100% of MPC Kinetic Holdings Pty Ltd (MPK) for an up
Slide 8: Transaction Details
TRANSACTION DETAILS OVERVIEW • Genus has entered into binding agreements to acquire 100% of the equity interests in MPC Kinetic Holdings Pty Ltd (MPK)1 • Upfront cash consideration of A$325m (cash free, debt free, normal working capital basis) • Deferred cash consideration of A$25m payable 6 months
Slide 9: MPK Overview
MPK OVERVIEW MPK is a leading provider of gas gathering, well services, major pipeline and renewable energy construction services to Tier 1 asset owners in Australia KEY CAPABILITIES / SERVICES MPC Kinetic (formerly Murphy Pipe and Civil est. in 2011) is a leading provider of gas gathering, Gas Gath
Slide 10: MPK Financial Performance
MPK FINANCIAL PERFORMANCE Strong recent performance driven by outperformance, early completion and release of profits on major renewable projects, which has now reached practical completion. FY27 performance expected to be lower, with earn-out consideration structured accordingly Revenue (A$ Million
Slide 11: Strategic Rationale
STRATEGIC RATIONALE Highly complementary and accretive2 acquisition positions Genus to better capitalise on Australia’s energy transition • Strategic diversification into the attractive gas and LNG sector which is critical for energy security and energy transition in Australia and Strategic diversif
Slide 12: Strategic Diversification into the Gas Sector
STRATEGIC DIVERSIFICATION INTO THE GAS SECTOR Provides Genus exposure to growth in the gas sector which is critical to Australia’s energy security and energy transition Gas is critical to energy security and the energy transition globally, further emphasised by the recent geopolitical events i n the
Slide 13: Complementary Skillsets Enhance Service Offering
COMPLEMENTARY SKILLSETS ENHANCE SERVICE OFFERING Highly complementary skillsets between MPK’s pipeline and civil capabilities and Genus’ electrical capabilities expected to enhance Genus’ service offering and self-perform capability For personal use only Early Works 1 • Site preparation: Removal of
Slide 14: Transformational and Accretive Transaction
TRANSFORMATIONAL AND ACCRETIVE TRANSACTION The acquisition is expected to transform Genus – with forecast ~99% increase in pro-forma FY26F EBITDA and ~96% increase in FY26F EBIT(A), with only a ~12% increase in pro-forma number of ordinary shares issued Pro-forma FY26F EBITDA (A$m) Pro-forma FY26F E
Slide 15: Deal Metrics and Scenario Analysis
DEAL METRICS AND SCENARIO ANALYSIS ~59% EPS(A) accretive on a pro-forma FY26F basis (assuming MPK’s 3 year average FY24-FY26F EBIT of A$75m), with sensitivity analysis confirming that the acquisition remains highly accretive even when assuming significantly lower earnings Based on Lower Upper MPK’s
Slide 16: Capital Raising Overview
For personal use only SECTION 2 CAPITAL RAISING OVERVIEW
Slide 17: Capital Raising Details
CAPITAL RAISING DETAILS Single tranche unconditional Placement to raise up to A$200m (before costs) at an offer price of A$9.25 per share Uses of Funds • Genus to raise up to A$200m (before costs) via a single tranche Uses1 A$m placement to institutional and sophisticated investors • Issue of up to
Slide 18: Pro-Forma Capital Structure
PRO-FORMA CAPITAL STRUCTURE Single tranche unconditional Placement to raise up to A$200m (before costs) at an offer price of A$9.25 per share Genus pro-forma @ Genus1,2,3 Transaction4 Placement Debt5 Placement price Price A$/sh 9.74 9.25 9.25 Existing ordinary shares m 181.5 21.6 203.1 Equity Value
Slide 19: Indicative Timetable
INDICATIVE TIMETABLE EVENT INDICATIVE DATE1 For personal use only Announcement of Transaction and Placement and Trading Halt Monday, 18 May 2026 Announcement of results of Placement Wednesday, 20 May 2026 Genus resumes trading on ASX Settlement of Placement Friday, 22 May 2026 Allotment and expected
Slide 20: Appendix
For personal use only APPENDIX
Slide 21: Genus FY2026 Guidance Upgrade
GENUS FY2026 GUIDANCE UPGRADE Genus Standalone Update • Genus’ previous FY2026 guidance as released on 22 January 2026, anticipated growth in normalised FY2026 EBITDA to be circa 35% compared to normalised FY2025 EBITDA of $67.4m. This implied a normalised FY2026 EBITDA of approximately A$91m. For p
Slide 22: Corporate Overview
CORPORATE OVERVIEW Genus Board of Directors Share Price History & Shareholder Information 12.00 10.00 Simon High David Riches Genus share price (A$/sh) For personal use only 8.00 Non-Executive Chairman Managing Director/Founder 6.00 4.00 2.00 José Martins Paul Gavazzi - Non-Executive Director Non-Ex
Slide 23: Key Risks and Offer Jurisdictions
For personal use only KEY RISKS AND OFFER JURISDICTIONS
Slide 24: Key Risks
KEY RISKS There are a number of risks, both specific to the Company and of a general nature, which may, either individually or in combination, affect the future operational and financial performance of the Company and the value of its Shares. The risks set out below are not, and should not be consid
Slide 25: Key Risks (cont.)
KEY RISKS (CONT.) 2. Transaction risks (cont.) In the event of default by the Sellers, the Company may have certain remedies, such as a right to recover damages for breach. However, there are a large number of private and individual Sellers (in addition to the two majority private equity fund manage
Slide 26: Key Risks (cont.)
KEY RISKS (CONT.) 2. Transaction risks (cont.) Market acceptance and There is a risk that Genus may not be able to effectively compete with other participants in the market in which it will operate in following completion of the Transaction. This may result in the performance of Genus competitor ris
Slide 27: Key Risks (cont.)
KEY RISKS (CONT.) 3. Business risks Genus also has in place various supply arrangements which may be terminated or not renewed in which case, the Company would be required to obtain inputs or services from other providers. There is a risk of insolvency or managerial failure by any of the contractors
Slide 28: Key Risks (cont.)
KEY RISKS (CONT.) 3. Business risks The Company may be subject to litigation, prosecutions, regulatory investigations and other proceedings, claims and disputes in the course of its business, including employment disputes, Risk of litigation, contractual disputes and claims for infringement of intel
Slide 29: Key Risks (cont.)
KEY RISKS (CONT.) 4. General risks The value of the Shares is determined by the stock market and are subject to a range of factors beyond the Company's control. These factors include, but are not limited to, the demand for, and availability of Shares, movements in interest rates, exchange rates, and
Slide 30: International Offer Restrictions
INTERNATIONAL OFFER RESTRICTIONS This document does not constitute an offer of new ordinary shares ("New Shares") of the Company in any jurisdiction in which it would be unlawful. In particular, this document may not be distributed to any person, and the New Shares may not be offered or sold, in any
Slide 31: International Offer Restrictions
INTERNATIONAL OFFER RESTRICTIONS This document has not been, and will not be, registered with or approved by any securities regulator in the European Union. Accordingly, this document may not be made available, nor may the New For personal use only European Union Shares be offered for sale, in the E